JP2021503004A5 - - Google Patents

Download PDF

Info

Publication number
JP2021503004A5
JP2021503004A5 JP2020544372A JP2020544372A JP2021503004A5 JP 2021503004 A5 JP2021503004 A5 JP 2021503004A5 JP 2020544372 A JP2020544372 A JP 2020544372A JP 2020544372 A JP2020544372 A JP 2020544372A JP 2021503004 A5 JP2021503004 A5 JP 2021503004A5
Authority
JP
Japan
Prior art keywords
isopropyl
indole
piperidine
pyridine
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020544372A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021503004A (ja
JP7265554B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/060590 external-priority patent/WO2019099336A1/en
Publication of JP2021503004A publication Critical patent/JP2021503004A/ja
Publication of JP2021503004A5 publication Critical patent/JP2021503004A5/ja
Application granted granted Critical
Publication of JP7265554B2 publication Critical patent/JP7265554B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020544372A 2017-11-14 2018-11-13 置換インドール化合物 Active JP7265554B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762585733P 2017-11-14 2017-11-14
US62/585,733 2017-11-14
PCT/US2018/060590 WO2019099336A1 (en) 2017-11-14 2018-11-13 Substituted indole compounds

Publications (3)

Publication Number Publication Date
JP2021503004A JP2021503004A (ja) 2021-02-04
JP2021503004A5 true JP2021503004A5 (hu) 2021-12-16
JP7265554B2 JP7265554B2 (ja) 2023-04-26

Family

ID=64565001

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020544372A Active JP7265554B2 (ja) 2017-11-14 2018-11-13 置換インドール化合物

Country Status (7)

Country Link
US (2) US20210253593A1 (hu)
EP (1) EP3710440B1 (hu)
JP (1) JP7265554B2 (hu)
KR (1) KR20200086709A (hu)
CN (1) CN111448190B (hu)
ES (1) ES2945435T3 (hu)
WO (1) WO2019099336A1 (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10071079B2 (en) 2016-06-29 2018-09-11 Bristol-Myers Squibb Company [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
CA3085590A1 (en) 2017-12-19 2019-06-27 Bristol-Myers Squibb Company Substituted indole compounds useful as tlr inhibitors
ES2904676T3 (es) * 2017-12-20 2022-04-05 Bristol Myers Squibb Co Compuestos de amino indol útiles como inhibidores de TLR
MX2020005622A (es) * 2017-12-20 2020-08-20 Bristol Myers Squibb Co Compuestos de indol sustituidos con arilo y heteroarilo.
JP7382938B2 (ja) * 2017-12-20 2023-11-17 ブリストル-マイヤーズ スクイブ カンパニー ジアザインドール化合物
WO2019155042A1 (en) 2018-02-12 2019-08-15 F. Hoffmann-La Roche Ag Novel sulfone compounds and derivatives for the treatment and prophylaxis of virus infection
EP3807270B1 (en) 2018-06-12 2023-09-13 F. Hoffmann-La Roche AG Novel heteroaryl heterocyclyl compounds for the treatment of autoimmune disease
EP3826724B1 (en) 2018-07-23 2022-10-05 F. Hoffmann-La Roche AG Novel piperazine compounds for the treatment of autoimmune disease
EP3847169A1 (en) 2018-09-04 2021-07-14 F. Hoffmann-La Roche AG Benzothiazole compounds for the treatment of autoimmune diseases
EP3847170B1 (en) 2018-09-06 2022-06-22 F. Hoffmann-La Roche AG Novel cyclic amidine compounds for the treatment of autoimmune disease
TW202028209A (zh) * 2018-09-27 2020-08-01 大陸商重慶複創醫藥研究有限公司 作為RET激酶抑制劑的取代的咪唑[1,2-a]吡啶和[1,2,4]三唑[1,5-a]吡啶化合物
WO2021067657A1 (en) * 2019-10-04 2021-04-08 Bristol-Myers Squibb Company Substituted carbazole compounds
AU2022219934A1 (en) * 2021-02-09 2023-08-10 Gilead Sciences, Inc. Thienopyrrole compounds
CR20230478A (es) 2021-04-16 2023-11-30 Gilead Sciences Inc Compuestos de tienopirrol.
TW202342016A (zh) * 2022-02-18 2023-11-01 美商必治妥美雅史谷比公司 用作tlr9抑制劑之經取代雙環雜芳基化合物
CN114591339B (zh) * 2022-05-10 2022-08-02 上海维申医药有限公司 一类Toll样受体抑制剂及其制备和应用
WO2024027712A1 (zh) * 2022-08-01 2024-02-08 索智生物科技(浙江)有限公司 含氮杂环类化合物、其制备方法及其应用
CN115417869B (zh) * 2022-09-19 2024-06-11 安徽大学 一种6-溴咪唑[1.2a]吡啶-3-甲酰胺的合成方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
IL143801A0 (en) 1998-12-18 2002-04-21 Axys Pharm Inc (hetero) aryl-bicyclic heteroaryl derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
MXPA02003887A (es) 1999-10-19 2002-09-30 Merck & Co Inc Inhibidores de tirosina cinasa.
CN100503608C (zh) 2002-01-07 2009-06-24 卫材R&D管理株式会社 脱氮嘌呤及其用途
KR20060016817A (ko) 2003-06-20 2006-02-22 콜리 파마슈티칼 게엠베하 소분자 톨-유사 수용체 (tlr) 길항제
WO2007115306A2 (en) 2006-04-04 2007-10-11 Myriad Genetics, Inc. Compounds for diseases and disorders
US20060235037A1 (en) * 2005-04-15 2006-10-19 Purandare Ashok V Heterocyclic inhibitors of protein arginine methyl transferases
DE102006033109A1 (de) 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
US8027888B2 (en) 2006-08-31 2011-09-27 Experian Interactive Innovation Center, Llc Online credit card prescreen systems and methods
DE602007012133D1 (de) 2006-12-01 2011-03-03 Andrew Burritt Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
WO2008152471A1 (en) 2007-06-12 2008-12-18 Coley Pharmaceutical Group, Inc. Quinazoline derivative useful as toll-like receptor antagonist
WO2009030996A1 (en) 2007-09-05 2009-03-12 Coley Pharmaceutical Group, Inc. Triazole compounds as toll-like receptor (tlr) agonists
EP2205085A1 (en) 2007-09-25 2010-07-14 Merck Sharp & Dohme Corp. 2-aryl or heteroaryl indole derivatives
EP2350032B1 (en) 2008-09-26 2016-05-25 Eisai R&D Management Co., Ltd. Benzoxazole compounds and methods of use
JP5529876B2 (ja) 2008-10-17 2014-06-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Mmp−13阻害剤として有用なヘテロアリール置換インドール化合物
TWI462920B (zh) 2009-06-26 2014-12-01 葛萊伯格有限公司 用於治療退化性及發炎疾病之新穎化合物
EP2453895B1 (en) 2009-07-16 2018-05-23 Mallinckrodt LLC (+) - morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
CN102574788A (zh) 2009-09-24 2012-07-11 弗·哈夫曼-拉罗切有限公司 作为crac调节剂的吲哚衍生物
CA2777245A1 (en) 2009-10-22 2011-04-28 Vertex Pharmaceuticals Incorporated Compositions for treatment of cystic fibrosis and other chronic diseases
US9241991B2 (en) 2010-10-21 2016-01-26 The Brigham And Women's Hospital, Inc. Agents, compositions, and methods for treating pruritus and related skin conditions
BR112013017943A2 (pt) 2011-01-12 2018-12-18 Array Biopharma Inc benzoazepinas substituídas como moduladores receptores do tipo toll
PT2663555T (pt) 2011-01-12 2017-03-23 Array Biopharma Inc Benzoazepinas substituídas como moduladores de recetores tipo-toll
CA2837227C (en) 2011-06-01 2022-05-10 Janus Biotherapeutics, Inc. Novel immune system modulators
CA2837207A1 (en) 2011-06-01 2012-12-06 Janus Biotherapeutics, Inc. Novel immune system modulators
KR101913619B1 (ko) 2011-06-09 2018-12-28 리젠 파마슈티컬스 소시에떼 아노님 Gpr-119의 조절제로서의 신규한 화합물
WO2013010904A1 (en) * 2011-07-15 2013-01-24 Janssen Pharmaceuticals, Inc. Novel substituted indole derivatives as gamma secretase modulators
EP2763677B1 (en) 2011-10-04 2020-02-26 Janus Biotherapeutics, Inc. Novel imidazole quinoline-based immune system modulators
WO2013172479A1 (en) 2012-05-18 2013-11-21 Dainippon Sumitomo Pharma Co., Ltd. Carboxylic acid compounds
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
EP2738172A1 (en) 2012-11-28 2014-06-04 Almirall, S.A. New bicyclic compounds as crac channel modulators
US9428495B2 (en) 2013-10-14 2016-08-30 Eisai R&D Management Co., Ltd. Selectively substituted quinoline compounds
JP2016540013A (ja) 2013-12-13 2016-12-22 武田薬品工業株式会社 Tlr阻害剤としてのピロロ[3,2−c]ピリジン誘導体
BR112017002811B1 (pt) 2014-08-15 2022-09-06 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Compostos de pirrolopirimidina usados como agonista de tlr7 e seu uso, composição farmacêutica e kit
US20170275287A1 (en) 2014-08-22 2017-09-28 Janus Biotherapeutics, Inc. Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
US10071079B2 (en) * 2016-06-29 2018-09-11 Bristol-Myers Squibb Company [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
SG11201900619XA (en) 2016-07-30 2019-02-27 Bristol Myers Squibb Co Dimethoxyphenyl substituted indole compounds as tlr7, tlr8 or tlr9 inhibitors
ES2902504T3 (es) 2016-09-09 2022-03-28 Bristol Myers Squibb Co Compuestos de indol sustituidos con piridilo

Similar Documents

Publication Publication Date Title
JP2021503004A5 (hu)
AU2019203444B2 (en) Bicyclic lactams and methods of use thereof
US11739098B2 (en) Substituted indole compounds
JP2020522570A5 (hu)
BR112021001292A2 (pt) compostos heterobicíclicos para inibir a atividade de shp2
JP2021506941A5 (hu)
JPWO2019191229A5 (hu)
RU2015131148A (ru) СОЕДИНЕНИЯ, ГЕТЕРОБИЦИКЛО-ЗАМЕЩЕННЫЕ-[1, 2, 4]ТРИАЗОЛО[1, 5c]ХИНАЗОЛИН-5-АМИНА, ОБЛАДАЮЩИЕ СВОЙСТВАМИ А2А АНТАГОНИСТОВ
JP2014506929A5 (hu)
CA2921880A1 (en) Alkynyl alcohols and methods of use
JP2016504363A5 (hu)
JPWO2020005873A5 (hu)
RU2018112230A (ru) Бициклические соединения в качестве ингибиторов atx
RU2014123316A (ru) Ингибиторы фосфодиэстеразы типа 10а
JP2014528482A5 (hu)
JPWO2020005877A5 (hu)
JP2021504380A5 (hu)
IL233872A (en) Compounds 4 - (benzoimidazole-2-yl) -thiazole and related azo
WO2022167682A1 (en) Azabicyclic shp2 inhibitors
KR20230107291A (ko) PPARγ 조절제 및 사용 방법
JPWO2020065613A5 (hu)
RU2021111918A (ru) Модуляторы моноацилглицерин-липазы
JPWO2020065614A5 (hu)
TW202334166A (zh) 螺三環ripk1抑制劑及其使用方法
JPWO2019238633A5 (hu)